Purchase Order AG32SDP150068

<p>This is a firm fixed-price purchase order contract awarded by a civilian federal agency to Global Biologics, LLC, a small disadvantaged business, for the provision of Directional RNASeq Libraries for Illumina. The contract has a ceiling value of $15,268.42 and was awarded on December 19, 2014 with a completion date of January 16, 2015. The contract does not have a set-aside designation. The funding agency is the U.S. federal agency, which is a civilian agency.</p>

This is a firm fixed price delivery order awarded by the Northeast Area of a Civilian agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The order is for the purchase of an Illumina MiSeq sequencer and associated sequencing supplies, to be used by the agency's Environmental and Molecular Forensic Sciences Laboratory (EMFSL) for sequencing the genomes of parasites and bacteria. The award has a ceiling value of $89,678.40 and a completion date of February...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of a MiSeq System sequencer. The award does not have a set-aside designation and has a ceiling value of $95,931. Illumina has a history of providing sequencing systems and related products and services to...

This firm fixed price purchase order was awarded by the Department of the Interior US Geological Survey Office of Acquisitions and Grants to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $78,695.00 contract is for a Comprehensive Service Plan for Illumina's MiSeq sequencing platform, to be performed at Illumina's facilities in Fort Collins, Colorado. The contract does not have a set-aside designation. Illumina has previously been awarded prime...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of a MiSeq benchtop DNA sequencer system. The total ceiling value of the contract is $119,937.50, with a performance period ending on December 2, 2013. The contract does not have any set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions,...

This is a firm fixed price purchase order contract awarded by the Office of Fossil Energy, a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the renewal of a service agreement for an Illumina MiSeq sequencing system, with a period of performance from December 14, 2024 to December 13, 2026 and a ceiling value of $31,424.12. The contract does not have a set-aside designation. Illumina has previously received prime federal...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of sequencing kits, with a ceiling value of $7,012.50 and a period of performance from May 15, 2014 to May 23, 2014. The contract has no set-aside designation. Illumina has a history of providing...

This is a firm fixed price purchase order awarded by the Plains Area of the Federal Agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is for the provision of 24x1 Infinium iSelect HD Custom Kits, which contain reagents for processing 48 DNA samples and analyzing 3,072 to 90,000 genetic loci. The total ceiling value of the award is $4,293.12, and there was no set-aside provision. Illumina has a history of providing sequencing systems,...

This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $87,570.20, is for the provision of NextGen sequencing genomes, with an ultimate completion date of October 31, 2015. Illumina has previously received prime federal contracts and subcontracts from agencies like the...

This is a Firm Fixed Price Delivery Order contract awarded by the National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit biotechnology manufacturer. The contract is for the provision of TruSeq and NovaSeq X DNA genome sequencing kits and samples, with a ceiling value of $248,205.26 and a period of performance ending on March 2, 2026. The award did not utilize any set-aside designations, reflecting Illumina's...